{"DataElement":{"publicId":"10420446","version":"1","preferredName":"Viable Small Cell Neoplasm Specimen Present Surgical Margin Distance Measurement","preferredDefinition":"Capable of life or normal growth and development._Limited in number, quantity, magnitude or extent._The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._Being or existing in a specified place or at the specified time.:Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","longName":"SMCL_MRG_DIST_MRMT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"10379794","version":"1","preferredName":"Viable Small Cell Neoplasm Specimen Present","preferredDefinition":"Capable of life or normal growth and development._Limited in number, quantity, magnitude or extent._The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._Being or existing in a specified place or at the specified time.","longName":"10379793v1.00:6352158v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"10379793","version":"1","preferredName":"Viable Small Cell Neoplasm","preferredDefinition":"Capable of life or normal growth and development._Limited in number, quantity, magnitude or extent._The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C25324:C25376:C12508:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Viable","conceptCode":"C25324","definition":"Capable of life or normal growth and development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Small","conceptCode":"C25376","definition":"Limited in number, quantity, magnitude or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-94EE-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-26","modifiedBy":"KUMMEROA","dateModified":"2022-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6352158","version":"1","preferredName":"Specimen Present","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:Being or existing in a specified place or at the specified time.","longName":"C19157:C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70C14108-5BC2-239A-E053-F662850A8478","latestVersionIndicator":"Yes","beginDate":"2018-07-11","endDate":null,"createdBy":"GALITG","dateCreated":"2018-07-11","modifiedBy":"ONEDATA","dateModified":"2018-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC439F5-94EF-2FB6-E053-731AD00AC155","latestVersionIndicator":"Yes","beginDate":"2022-05-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-05-26","modifiedBy":"KUMMEROA","dateModified":"2022-08-22","changeDescription":null,"administrativeNotes":"2022.8.22 Released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3915850","version":"1","preferredName":"Surgical Margin Tumor Distance Measurement","preferredDefinition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","longName":"3915850v1.0","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008574","version":"1","preferredName":"Surgical Margin Measurements","preferredDefinition":"any measurements of a patient's surgical margins.","longName":"SURG_MARG_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB880E47-7AFF-254C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184312","version":"1","preferredName":"Measurement","preferredDefinition":"Measurement; the size or magnitude of something.","longName":"C25209","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"DB6C8AC6-1DB1-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"DWARZEL","dateModified":"2006-10-26","changeDescription":"Move to caBIG context as teh preferred Rep class for Measurement","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E8408410-0D1C-46E3-E040-BB89AD434E06","latestVersionIndicator":"Yes","beginDate":"2013-10-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-08","modifiedBy":"TAYLORT","dateModified":"2017-08-07","changeDescription":"8/7/17 tt transferred context and added registration status, CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Distance of viable small cell tumor from closest margin? (mm)","type":"Preferred Question Text","description":"Distance of viable small cell tumor from closest margin? (mm)","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-637B-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-03","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-06-03","modifiedBy":"KUMMEROA","dateModified":"2022-08-22","changeDescription":null,"administrativeNotes":"Created to support ARST2032_ghd.  2022.8.22 Released. ak","unresolvedIssues":null,"deletedIndicator":"No"}}